The hernia repair market projected to grow at a CAGR of 3.0% from 2018 to 2023. The hernia repair market is projected to reach USD 4.75 billion by 2023 from USD 4.09 billion in 2018, at a CAGR of 3.0%. Factors such as the increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and favorable reimbursement scenario in developed countries are driving the growth of this market. However, the unfavorable reimbursement scenario in developing countries, the high cost associated with mesh repair, and the development and adoption of new surgical techniques such as the Desarda technique are expected to restrain the growth of this market.
The mesh fixators segment is expected to be the fastest-growing segment during the forecast period. Based on product, the market is segmented into hernia mesh and mesh fixators.The hernia mesh fixators segment is expected to register the highest growth rate during the forecast period, owing to the increasing awareness about the advantages associated with non-mechanical type of mesh fixators such as glue.
The hernia mesh fixators market is segmented into sutures, tack applicators, and glue applicators.
The inguinal hernia segment is estimated to account for the largest share of the hernia mesh market in 2018. Based on surgery type, the hernia mesh market is segmented into inguinal hernia, incisional/ventral hernia, femoral hernia, and umbilical hernia.Of these, the inguinal hernia segment is expected to account for the largest market share in 2018.
The large share of this segment is attributed to the high number of inguinal hernia repair surgeries performed worldwide every year.
Asia Pacific expected to register the highest growth rate in the hernia repair market. Geographically, the hernia repair market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to register the highest growth rate during the forecast period, owing to the presence of a large target patient population, improving diagnosis and treatment rates for hernia, and growing adoption of advanced treatment options.
Breakdown of supply-side primary interviews: • By Company Type - Tier 1 – 31%, Tier 2 – 49% and Tier 3 – 20% • By Designation – – C-level – 28%, Director-level – 19%, Others – 53% • By Region – North America - 31%, Europe – 33%, APAC – 19%, RoW – 17%
The major players in the hernia repair market profiled in this report are Covidien ( Part of Medtronic) (Ireland), Ethicon (Part of Johnson & Johnson) (US), B. Braun (Germany), C.R. Bard (Part of Becton Dickinson) (US), W. L. Gore (US), LifeCell (Part of Allergan) (Ireland), Maquet (Part of Getinge) (Sweden), Cook Medical (US), Integra (US), DIPROMED (Italy), FEG (Germany), Cousin Biotech (France), Herniamesh (Italy), Aspide Medical (France), TransEasy Medical (China), and Via Surgical (Israel).
Research Coverage This report studies the hernia repair market based on product, surgery and region.The report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market.
The report forecasts the revenue of the market segments with respect to ten countries.
Reasons to Buy the Report: From an insights perspective, this research report has focused on various levels of analysis— market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the hernia repair market, and high-growth regions.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares.
Our reports have been used by over 10K customers, including:
269 pages •
By The Business Research Company
• Aug 2021
Anatomic Pathology Equipment and Consumables Market Opportunities And Strategies To 2030: COVID-19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global anatomic pathology equipment and consumables market as it emerges from the COVID 19 shut down. Description: Where...
The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021-2028. The market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing...
Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease - Drugs in Development, 2021, provides an overview of the Non Alcoholic Fatty Liver Disease (Gastrointestinal)...
Best foot forward: Revenue will likely rise as more healthcare providers stress the importance of preventive care Abstract Podiatrists in the US Over the five years to 2019, the Podiatrists industry has stepped in the right direction. Revenue growth has been supported by the aging US population and...
Stretch goals: Rising disposable incomes and an aging population will drive revenue growth Abstract Physical Therapists in the US Over the five years to 2019, the role of physical therapy in promoting health and wellness has increased, benefiting this industry. As the number of individuals aged 50 and...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
17 pages •
By Euromonitor International
• Jan 2021
Natural increase will be the sole driver of population expansion in the Dominican Republic up to 2040. While ageing will be a key trend, with rapid growth in the elderly and a decline in the younger age groups, the country will remain relatively young as birth rates remain comparatively high. Nevertheless, as population composition alters...
17 pages •
By Euromonitor International
• Oct 2020
A combination of natural increase and positive net migration will drive population growth in Ireland up to 2040. Ageing will continue to be a key demographic trend, though Ireland will remain relatively young in a regional context due to comparatively high birth rates. Longevity will continue to improve, but certain health issues will rise...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.